STING1 and head and neck squamous cell carcinoma: In summary, while the cGAS-STING signaling pathway demonstrates immense potential in HNSCC therapy, further research and clinical practice are required to ascertain its efficacy and safety in both HPV-positive and HPV-negative patients.